Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term simvastatin in children with Neurofibromatosis type 1
2009-010965-22Phase 3Completed
- Sponsor
- Erasmus MC
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of simvastatin in neurofibromatosis type 1 (NF1) (2 arms), sponsored by Erasmus MC. Primary endpoints: Cognitive function and Behavioral problems. Started Sep 2009; status: completed.
02
Drugs
simvastatin
03
Conditions
neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on 2009-010965-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010965-22.